Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 4
1967 9
1981 1
2006 1
2009 1
2011 5
2013 2
2014 9
2015 5
2016 5
2017 4
2018 8
2019 12
2020 9
2021 13
2022 15
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, Kristen AV, Grogan M, Witteles R, Damy T, Drachman BM, Shah SJ, Hanna M, Judge DP, Barsdorf AI, Huber P, Patterson TA, Riley S, Schumacher J, Stewart M, Sultan MB, Rapezzi C; ATTR-ACT Study Investigators. Maurer MS, et al. N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27. N Engl J Med. 2018. PMID: 30145929 Free article. Clinical Trial.
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
Boada C, Zinger A, Tsao C, Zhao P, Martinez JO, Hartman K, Naoi T, Sukhoveshin R, Sushnitha M, Molinaro R, Trachtenberg B, Cooke JP, Tasciotti E. Boada C, et al. Among authors: trachtenberg b. Circ Res. 2020 Jan 3;126(1):25-37. doi: 10.1161/CIRCRESAHA.119.315185. Epub 2019 Oct 24. Circ Res. 2020. PMID: 31647755 Free article.
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure.
Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS. Ghoneem A, et al. Among authors: trachtenberg b. Curr Probl Cardiol. 2023 Jun;48(6):101667. doi: 10.1016/j.cpcardiol.2023.101667. Epub 2023 Feb 23. Curr Probl Cardiol. 2023. PMID: 36828040 Review.
Insights on Infiltrative and Restrictive Cardiomyopathies.
Trachtenberg B, Kassi M. Trachtenberg B, et al. Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):1-3. doi: 10.14797/mdcvj.1098. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35414859 Free PMC article. No abstract available.
Future Directions in Cardio-Oncology.
Trachtenberg BH. Trachtenberg BH. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):300-302. doi: 10.14797/mdcj-15-4-300. Methodist Debakey Cardiovasc J. 2019. PMID: 31988691 Free PMC article. Review. No abstract available.
The Burgeoning Field of Cardio-Oncology.
Trachtenberg BH. Trachtenberg BH. Methodist Debakey Cardiovasc J. 2019 Oct-Dec;15(4):241-242. doi: 10.14797/mdcj-15-4-241. Methodist Debakey Cardiovasc J. 2019. PMID: 31988683 Free PMC article. No abstract available.
Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.
Morales A, Kinnamon DD, Jordan E, Platt J, Vatta M, Dorschner MO, Starkey CA, Mead JO, Ai T, Burke W, Gastier-Foster J, Jarvik GP, Rehm HL, Nickerson DA, Hershberger RE; DCM Precision Medicine study of the DCM Consortium; DCM Consortium institutions and personnel participating in this study: Study Principal Investigator and Co-Investigators,DCM Consortium Clinical Site Principal Investigators and Clinical Site Other Significant Contributors (OSC). The following clinical sites and individuals contributed to the submission of RO 1 H L 128857 as Site Principal Investigators (Site Pl) or as Other Significant Contributors (OSC),Dr. Huggins also served as study co-principal investigator,The following clinical site was added following approval of NHGRI supplemental funding but prior to initiation of enrollment,The following clinical sites were added following study activation. Morales A, et al. Circ Genom Precis Med. 2020 Apr;13(2):e002480. doi: 10.1161/CIRCGEN.119.002480. Epub 2020 Mar 11. Circ Genom Precis Med. 2020. PMID: 32160020 Free PMC article.
Inflammatory Cardiomyopathic Syndromes.
Trachtenberg BH, Hare JM. Trachtenberg BH, et al. Circ Res. 2017 Sep 15;121(7):803-818. doi: 10.1161/CIRCRESAHA.117.310221. Circ Res. 2017. PMID: 28912184 Review.
107 results